US 9926324
Heteroaromatic compounds as PI3 kinase modulators and methods of use
granted A61KA61K31/437A61K31/5025
Quick answer
US patent 9926324 (Heteroaromatic compounds as PI3 kinase modulators and methods of use) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61K31/5025, A61K31/53, A61K45/06